Effect of DCS on Post-Endodontic Pain
Summary
The aim of this randomized, triple-blind, parallel-group clinical trial was to evaluate the effects of calcium hydroxide (CH), diclofenac sodium (DCS), and their combination (CH+DCS) as intracanal medicaments on post-endodontic pain in mandibular molars diagnosed with symptomatic apical periodontitis. Ninety patients were randomly assigned to three groups (CH, DCS, or CH+DCS; n=30 each). Pain intensity was recorded using a 100 mm Visual Analog Scale (VAS) over 7 days following treatment, and the number of analgesic tablets taken was also recorded. Statistical analyses were performed using Kruskal-Wallis, Friedman, Wilcoxon signed-rank, and Chi-square tests, with significance set at 0.05. The null hypothesis stated that there would be no significant difference in post-endodontic pain among the groups.
Timeline
- Start
- 2024-01-22
- Primary completion
- 2024-05-17
- Completion
- 2024-05-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcium Hydroxide | Other / unclassified | 950 mg | Other |
| Subject | Calcium Hydroxide | Other / unclassified | 1 g | Other |
| Subject | Diclofenac | Other / unclassified | 50 mg | Other |
| Subject | Diclofenac | Other / unclassified | 1 g | Other |